The University of Chicago Header Logo

Connection

David Grinblatt to Immunosuppressive Agents

Back to Details
This is a "connection" page, showing publications David Grinblatt has written about Immunosuppressive Agents.
David Grinblatt
Connection Strength
0.052
Immunosuppressive Agents
  1. Thalidomide has limited single-agent activity in relapsed or refractory indolent non-Hodgkin lymphomas: a phase II trial of the Cancer and Leukemia Group B. Br J Haematol. 2008 Feb; 140(3):313-9.
    View in: PubMed
    Score: 0.052
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.